OncoGenex Hires Burris

Bothell, WA-based OncoGenex Pharmaceuticals (NASDAQ: [[ticker:OGXI]])  said today it has hired Michelle Burris as its executive vice president of operations and chief financial officer. Burris most recently served as senior vice president and chief operating officer at Seattle-based Trubion Pharmaceuticals (NASDAQ: [[ticker:TRBN]]) until it was acquired by Emergent BioSolutions. Burris, a veteran chief financial officer with experience at Dendreon and Corixa, became connected to OncoGenex when she joined the board of Sonus Pharmaceuticals in 2004. She stayed on the OncoGenex board after it acquired Sonus in 2008. She will start at the new company at a flush moment, as it just raised $50 million last month through a securities offering.

Author: Luke Timmerman

Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.